Drugs Made In America Acquisition Corp.

DMAA·NasdaqGM
Compare
10.86+0.01 (+0.09%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.85
Open10.85
Day range10.8510.86
52-week range10.2810.89
Off day high0.00%
Off 52-week high−0.28%
Volume54.87K
Avg. volume (3M)21.34K
Market cap263.65M
EPS (TTM)0.1800
Forward P/E—
P/E ratio (TTM)60.33
Dividend yield—
Beta (5Y)—
Shares outstanding24.28M
Short interest—
Earnings dateMay 20, 2025
Analyst target—
Profit margin—

Against its peers

Compare in full ›
DMAA DMII NWAX TDAC ADAC ACGC
Market cap 263.65M 649.10M 499.99M 209.31M 290.09M 292.75M
P/E (TTM) 60.3 34.0 — 41.7 — —
Forward P/E — — — — — —
Price/book -35.6 -36.3 1,673.3 -27.2 -29.0 -75.1
Dividend yield — — — — — —
1-year change +5.39% +3.14% −1.57% +4.58% +2.44% +1.31%
Today +0.09% 0.00% −0.05% +0.14% −0.59% 0.00%

The closest companies by business and industry (Shell Companies). Prices may be delayed up to 15 min.

Related companies

Compare ›

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All DMAA news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.